Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells (Q40636941)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 2002

Language	Label	Description	Also known as
English	Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells	scientific article published on September 2002

Statements

scholarly article

1 reference

Europe PubMed Central

22 September 2017

Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells (English)

1 reference

Europe PubMed Central

22 September 2017

apoptotic process

0 references

author name string

Qin He

1

1 reference

Europe PubMed Central

22 September 2017

Xiuquan Luo

2

1 reference

Europe PubMed Central

22 September 2017

Ying Huang

3

1 reference

Europe PubMed Central

22 September 2017

M Saeed Sheikh

4

1 reference

Europe PubMed Central

22 September 2017

language of work or name

0 references

publication date

1 September 2002

1 reference

Europe PubMed Central

22 September 2017

1 reference

Europe PubMed Central

22 September 2017

21

1 reference

Europe PubMed Central

22 September 2017

39

1 reference

Europe PubMed Central

22 September 2017

6032-6040

1 reference

Europe PubMed Central

22 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1205897

0 references

Apoptosis control by death and decoy receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

BCL-2 family members and the mitochondria in apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

A Fas-associated death domain protein-dependent mechanism mediates the apoptotic action of non-steroidal anti-inflammatory drugs in the human leukemic Jurkat cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

Aspirin and neoplasia of the digestive tract: is there a chemopreventive effect?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

From bench to clinic with apoptosis-based therapeutic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

Apoptosis-based therapies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

Apoptosis signaling by death receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

Role of p53 family members in apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

The role of cyclooxygenases in inflammation, cancer, and development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

Role of BAX in the apoptotic response to anticancer agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

21 January 2018

Cyclooxygenase-2 and carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

7 January 2021

based on heuristic

inferred from DOI database lookup

Single-agent immunosuppression after liver transplantation: what is possible?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

7 January 2021

based on heuristic

inferred from DOI database lookup

Ultraviolet-irradiation-induced apoptosis is mediated via ligand independent activation of tumor necrosis factor receptor 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205897

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1205897

1 reference

Europe PubMed Central

22 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

22 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40636941&oldid=1904031440"